More Business Wire
View Older Stories View Newer Stories-
New GenAI Assistants Add Personalized Experiences and Support to McGraw Hill’s K-12 Programs
-
World First: Autonomous Racing Leaps Forward in Abu Dhabi as A2RL Season 2 Showcases Record Speed, Bold Overtakes and Real-Time AI Decision-Making
-
Davis Polk Welcomes Leading Sports Partner Jon Oram
-
OCEAN Dx Rapid Diagnostic Test for Sepsis Matched Gold Standard During a Clinical Evaluation Study
-
Americans are Urged to Cut Nitrates on National Nitrate Awareness Day and During Monthlong No Nitrates Campaign in November
-
GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®
-
Caranx Medical Announces First Clinical Use of the TAVIPILOT Soft, Cleared by FDA for Commercial in July
-
ChristianaCare Gene Editing Institute Achieves CRISPR Breakthrough That Reverses Chemotherapy Resistance in Lung Cancer
-
Medical Properties Trust Increases Regular Quarterly Dividend
-
NETGEAR Introduces the Nighthawk 5G M7 Hotspot with New Mobile App and eSIM Marketplace to Enable Fast Portable Connectivity
-
Intuit and Rehmann Partner to Fuel Mid-Market Business Growth with Powerful AI-Native ERP Solution and Advisory Services
-
Starco Brands Reports Third Quarter 2025 Financial Results
-
Deepgram Receives 2025 Customer Experience Innovation Award From CUSTOMER Magazine
-
Empery Digital Announces Update on Share Repurchase Program
-
Circuitry.ai and Service Xcelerator Announce Strategic Partnership to Transform Warranty, Claims & Service Operations With AI
-
NiCE Appoints Arun Chandra as Chief Operating Officer to Lead Newly Formed Global Customer Operations
-
CorriXR Therapeutics Announces Publication of Preclinical Data Demonstrating Potential of CRISPR-Directed Gene Editing to Overcome Drug Resistance in Solid Tumors
-
Colony Bankcorp, Inc. and TC Bancshares, Inc. Announce Regulatory and Shareholder Approvals Received for Merger
-
Ankyra Therapeutics Announces First Patient Dosed in Phase 1b Trial Evaluating First-in-Class Anchored Immunotherapy in Combination with Immune Checkpoint Blockade in Patients with Lung Cancer
-
Rockland Capital Closes Oversubscribed Fund V at $1.2 Billion
-
87% of Institutional Investors Have Declined or Reconsidered Fund Commitments Due to AML/KYC Concerns
-
Everus Names Kenny Whipple Vice President of Business Development
-
Graco Inc. Acquires Radia Products, a Leading Manufacturer of Paint Mixing Equipment
-
RXO Announces Participation at Upcoming Investor Conferences
-
VanEck Debuts Solana ETF: VSOL Launches with Zero Fees
-
Cardano Summit 2025 Concludes In Berlin: Trust Emerges As The Winner with Traditional Financial Firms Feeling Blockchain FOMO
-
Molina Healthcare Announces Proposed Offering of $750 Million of Senior Notes Due 2031
-
TearOptix Secures Strategic Funding to Transform Presbyopia Treatment and Announces Creation of Scientific Advisory Board
-
Onto Innovation Completes Acquisition of Unique Materials Composition and Electrical Analysis Product Lines from Semilab International
-
Accenture Invests in Alembic to Reinvent Marketing Measurement with Data and Causal AI
-
Boston Omaha Corporation Announces Adoption of $30 Million Class A Common Stock Repurchase Program
-
MUSASHI JAPAN by TAIMATSU Launches “Dual Blades” – A Black Friday Experience Redefining Luxury Craftsmanship
-
Alembic Raises $145 Million to Accelerate Enterprise Adoption of Causal AI
-
Sonoma Biotherapeutics Announces Transition of Jeff Bluestone, PhD, to Advisor; Appoints Stephen Dilly, MBBS, PhD, as President and Chief Executive Officer
-
Butterfly Network Launches Compass AI to Power the Next Generation of POCUS Program Management
-
Kreate Recognized by the Home Depot as Partner of the Year
-
Safe Pro Group Accelerates Growth Across AI, Drone Services, and Ballistic Divisions Following $20+ Million in Strategic Investments
-
ICE Launches Latest Phase of its VaR-Based Portfolio Margining Methodology ICE Risk Model 2
-
Polpharma Biologics Confirms U.S. Launch of Tyruko® (natalizumab), the First and Only Biosimilar for Multiple Sclerosis
-
Veradigm Launches Enhanced Ambient Scribe Capabilities
-
VerifyMe Reports Third Quarter 2025 Financial Results
-
Broken String Biosciences Announces New Leadership to Drive Commercialization of INDUCE-seq® Platform for Gene Editing On- and Off-target Characterization
-
Sumitomo Mitsui Trust Bank Advances Mobile Banking Security with SCSK and OneSpan’s FIDO Cloud Authentication Solution
-
Ascent Industries Eliminates $2.1M in Costs, Further Strengthening Earnings Profile as Pure-Play Specialty Chemicals Platform
-
ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results
-
National CineMedia, Inc. Announces Strategic Acquisition of Spotlight Cinema Networks to Enhance Advertising Network and Expand Reach Among Luxury Audiences
-
Ventas Announces Planned Retirement of Peter J. Bulgarelli, EVP, Outpatient Medical & Research and CEO of Lillibridge Healthcare Services
-
Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter
-
CrowdStrike Named One of the Top 25 Workplaces in the World in 2025
-
Applied DNA Rebrands as BNB Plus Corp., Elects Josh Kruger as Chairman of the Board
